Therapy success and survival in patients with valvular heart disease and implantable cardioverter defibrillator

Rosenheck, Shimon; Weiss, A. Teddy; Sharon, Zehava

doi:10.1016/j.ijcard.2008.12.144

Cited by 10 publications

(5 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Wady zastawkowe serca, jako domniemana przeważająca etiologia arytmii, występowały u ok. 7% pacjentów kierowanych na wszczepienie ICD w celu prewencji wtórnej [602]. W tym jednoośrodkowym badaniu wykazano, że u 31 pacjentów z wadą zastawkową i złośliwymi tachyarytmiami komorowymi, których zabezpieczono za pomocą ICD, wyniki leczenia były korzystne.…”

Section: Wady Zastawkowe Sercaunclassified

See 1 more Smart Citation

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Priori

Blomström‐Lundqvist²,

Mazzanti³

et al. 2015

Kardiol Pol

233

337

View full text Add to dashboard Cite

Section: Wady Zastawkowe Sercaunclassified

“…W tym jednoośrodkowym badaniu wykazano, że u 31 pacjentów z wadą zastawkową i złośliwymi tachyarytmiami komorowymi, których zabezpieczono za pomocą ICD, wyniki leczenia były korzystne. Przeżywalność w tej grupie była nie gorsza niż u pacjentów z CAD i korzystniejsza niż u pacjentów z DCM [602]. Jak stwierdzili Yang i wsp.…”

Section: Wady Zastawkowe Sercaunclassified

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Priori

Blomström‐Lundqvist²,

Mazzanti³

et al. 2015

Kardiol Pol

233

337

View full text Add to dashboard Cite

“…Amiodarone can be an effective adjunctive therapy for recurrent non-sustained VT but efficacy for preventing SCD is unproven. ICD implantation in patients with VHD (~7% of all secondary preventions) provides appropriate protection, with similar rate of ICD shocks and mortality vs. patients with CAD or dilated cardiomyopathy ( 115 , 116 ). Associated cardiac resynchronization therapy may be considered ( 117 ).…”

Section: Aortic Stenosismentioning

confidence: 99%

Arrhythmias in Patients With Valvular Heart Disease: Gaps in Knowledge and the Way Forward

Kubala

Chillou

Bohbot

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

The prevalence of both organic valvular heart disease (VHD) and cardiac arrhythmias is high in the general population, and their coexistence is common. Both VHD and arrhythmias in the elderly lead to an elevated risk of hospitalization and use of health services. However, the relationships of the two conditions is not fully understood and our understanding of their coexistence in terms of contemporary management and prognosis is still limited. VHD-induced left ventricular dysfunction/hypertrophy and left atrial dilation lead to both atrial and ventricular arrhythmias. On the other hand, arrhythmias can be considered as an independent condition resulting from a coexisting ischemic or non-ischemic substrate or idiopathic ectopy. Both atrial and ventricular VHD-induced arrhythmias may contribute to clinical worsening and be a turning point in the natural history of VHD. Symptoms developed in patients with VHD are not specific and may be attributable to hemodynamical consequences of valve disease but also to other cardiac conditions including arrhythmias which are notably prevalent in this population. The issue how to distinguish symptoms related to VHD from those related to atrial fibrillation (AF) during decision making process remains challenging. Moreover, AF is a traditional limit of echocardiography and an important source of errors in assessment of the severity of VHD. Despite recent progress in understanding the pathophysiology and prognosis of postoperative AF, many questions remain regarding its prevention and management. Furthermore, life-threatening ventricular arrhythmias can predispose patients with VHD to sudden cardiac death. Evidence for a putative link between arrhythmias and outcome in VHD is growing but available data on targeted therapies for VHD-related arrhythmias, including monitoring and catheter ablation, is scarce. Despite growing evidences, more research focused on the prognosis and optimal management of VHD-related arrhythmias is still required. We aimed to review the current evidence and identify gaps in knowledge about the prevalence, prognostic considerations, and treatment of atrial and ventricular arrhythmias in common subtypes of organic VHD.

show abstract

“…ЕОК IC (УУР C, УДД 4) Комментарии. Хирургическая коррекция острой аортальной регургитации, возникшей на фоне эндокардита и сопровождающейся УЖТ, рекомендована при отсутствии противопоказаний к такому методу лечения [495][496][497].…”

Section: еок Iibс (уур с удд 4) синдром бругадаunclassified

Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines

Лебедев¹,

Михайлов²,

Неминущий³

et al. 2021

Russ J Cardiol

View full text Add to dashboard Cite

show abstract

Therapy success and survival in patients with valvular heart disease and implantable cardioverter defibrillator

Cited by 10 publications

References 12 publications

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Arrhythmias in Patients With Valvular Heart Disease: Gaps in Knowledge and the Way Forward

Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines

Contact Info

Product

Resources

About